Modification of kindled amygdaloid seizures by opiate agonists and antagonists

Timothy E Albertson, R. M. Joy, L. G. Stark

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

The effects of 19 opiate agonists and antagonists on kindled amygdaloid seizures in the rat were studied. The mu agonists tended to reduce the length of elicited afterdischarges and behavioral ranks, while markedly increasing postictal electroencephalogram spikes and behavioral arrest time. These effects were reversed by naloxone. The kappa agonists reduced behavioral rank and variably reduced afterdischarge length with a concomitant lengthening of postictal behavioral arrest time and number of electroencephalogram spikes. The putative sigma agonist, SKF 10,047, reduced afterdischarge durations only at the higher doses tested. The decreases found after the sigma agonists in postictal electroencephalogram spiking and time of behavioral arrest were not reversed by naloxone. Only the lower doses of normeperidine were found to decrease seizure thresholds. The mixed agonist/antagonists (MAA) cyclazocine and cyclorphan markedly increased seizure threshold and reduced afterdischarge duration and behavioral rank. Only the MAA pentazocine tended to increase threshold but not suprathreshold afterdischarge durations. The order of ability to modify the ictal events was MAA (selected) > kappa agonists > mu agonists > sigma agonists. The increase in postictal events (behavior arrest and spikes) was caused most effectively by pretreatment with mu agonists > kappa agonists > selected MAA > sigma agonists. Additional studies were done with daily injections of cyclazocine and ethylketocyclazocine (kappa agonist) during the acquisition of the kindled amygdaloid seizure. Pretreatment by cyclazocine, but not ethylketocyclazone, before stimulation significantly retarded the progressive development of the elicited afterdischarge and behavioral rank. Thus, cyclazocine appears to have marked anticonvulsant properties in this model of epilepsy.

Original languageEnglish (US)
Pages (from-to)620-627
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume228
Issue number3
StatePublished - 1984

Fingerprint

Opiate Alkaloids
Cyclazocine
Seizures
Electroencephalography
Naloxone
Ethylketocyclazocine
Pentazocine
Aptitude
Anticonvulsants
Epilepsy
Stroke
Injections

ASJC Scopus subject areas

  • Pharmacology

Cite this

Modification of kindled amygdaloid seizures by opiate agonists and antagonists. / Albertson, Timothy E; Joy, R. M.; Stark, L. G.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 228, No. 3, 1984, p. 620-627.

Research output: Contribution to journalArticle

@article{14a5eb926de04c5fbcdeaa1ed307c84d,
title = "Modification of kindled amygdaloid seizures by opiate agonists and antagonists",
abstract = "The effects of 19 opiate agonists and antagonists on kindled amygdaloid seizures in the rat were studied. The mu agonists tended to reduce the length of elicited afterdischarges and behavioral ranks, while markedly increasing postictal electroencephalogram spikes and behavioral arrest time. These effects were reversed by naloxone. The kappa agonists reduced behavioral rank and variably reduced afterdischarge length with a concomitant lengthening of postictal behavioral arrest time and number of electroencephalogram spikes. The putative sigma agonist, SKF 10,047, reduced afterdischarge durations only at the higher doses tested. The decreases found after the sigma agonists in postictal electroencephalogram spiking and time of behavioral arrest were not reversed by naloxone. Only the lower doses of normeperidine were found to decrease seizure thresholds. The mixed agonist/antagonists (MAA) cyclazocine and cyclorphan markedly increased seizure threshold and reduced afterdischarge duration and behavioral rank. Only the MAA pentazocine tended to increase threshold but not suprathreshold afterdischarge durations. The order of ability to modify the ictal events was MAA (selected) > kappa agonists > mu agonists > sigma agonists. The increase in postictal events (behavior arrest and spikes) was caused most effectively by pretreatment with mu agonists > kappa agonists > selected MAA > sigma agonists. Additional studies were done with daily injections of cyclazocine and ethylketocyclazocine (kappa agonist) during the acquisition of the kindled amygdaloid seizure. Pretreatment by cyclazocine, but not ethylketocyclazone, before stimulation significantly retarded the progressive development of the elicited afterdischarge and behavioral rank. Thus, cyclazocine appears to have marked anticonvulsant properties in this model of epilepsy.",
author = "Albertson, {Timothy E} and Joy, {R. M.} and Stark, {L. G.}",
year = "1984",
language = "English (US)",
volume = "228",
pages = "620--627",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Modification of kindled amygdaloid seizures by opiate agonists and antagonists

AU - Albertson, Timothy E

AU - Joy, R. M.

AU - Stark, L. G.

PY - 1984

Y1 - 1984

N2 - The effects of 19 opiate agonists and antagonists on kindled amygdaloid seizures in the rat were studied. The mu agonists tended to reduce the length of elicited afterdischarges and behavioral ranks, while markedly increasing postictal electroencephalogram spikes and behavioral arrest time. These effects were reversed by naloxone. The kappa agonists reduced behavioral rank and variably reduced afterdischarge length with a concomitant lengthening of postictal behavioral arrest time and number of electroencephalogram spikes. The putative sigma agonist, SKF 10,047, reduced afterdischarge durations only at the higher doses tested. The decreases found after the sigma agonists in postictal electroencephalogram spiking and time of behavioral arrest were not reversed by naloxone. Only the lower doses of normeperidine were found to decrease seizure thresholds. The mixed agonist/antagonists (MAA) cyclazocine and cyclorphan markedly increased seizure threshold and reduced afterdischarge duration and behavioral rank. Only the MAA pentazocine tended to increase threshold but not suprathreshold afterdischarge durations. The order of ability to modify the ictal events was MAA (selected) > kappa agonists > mu agonists > sigma agonists. The increase in postictal events (behavior arrest and spikes) was caused most effectively by pretreatment with mu agonists > kappa agonists > selected MAA > sigma agonists. Additional studies were done with daily injections of cyclazocine and ethylketocyclazocine (kappa agonist) during the acquisition of the kindled amygdaloid seizure. Pretreatment by cyclazocine, but not ethylketocyclazone, before stimulation significantly retarded the progressive development of the elicited afterdischarge and behavioral rank. Thus, cyclazocine appears to have marked anticonvulsant properties in this model of epilepsy.

AB - The effects of 19 opiate agonists and antagonists on kindled amygdaloid seizures in the rat were studied. The mu agonists tended to reduce the length of elicited afterdischarges and behavioral ranks, while markedly increasing postictal electroencephalogram spikes and behavioral arrest time. These effects were reversed by naloxone. The kappa agonists reduced behavioral rank and variably reduced afterdischarge length with a concomitant lengthening of postictal behavioral arrest time and number of electroencephalogram spikes. The putative sigma agonist, SKF 10,047, reduced afterdischarge durations only at the higher doses tested. The decreases found after the sigma agonists in postictal electroencephalogram spiking and time of behavioral arrest were not reversed by naloxone. Only the lower doses of normeperidine were found to decrease seizure thresholds. The mixed agonist/antagonists (MAA) cyclazocine and cyclorphan markedly increased seizure threshold and reduced afterdischarge duration and behavioral rank. Only the MAA pentazocine tended to increase threshold but not suprathreshold afterdischarge durations. The order of ability to modify the ictal events was MAA (selected) > kappa agonists > mu agonists > sigma agonists. The increase in postictal events (behavior arrest and spikes) was caused most effectively by pretreatment with mu agonists > kappa agonists > selected MAA > sigma agonists. Additional studies were done with daily injections of cyclazocine and ethylketocyclazocine (kappa agonist) during the acquisition of the kindled amygdaloid seizure. Pretreatment by cyclazocine, but not ethylketocyclazone, before stimulation significantly retarded the progressive development of the elicited afterdischarge and behavioral rank. Thus, cyclazocine appears to have marked anticonvulsant properties in this model of epilepsy.

UR - http://www.scopus.com/inward/record.url?scp=0021352926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021352926&partnerID=8YFLogxK

M3 - Article

VL - 228

SP - 620

EP - 627

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -